Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
Mini Samples ELISA Kit for Complement Component 5 (C5)
CPAMD4; C5a anaphylatoxin; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4
- Product No.MEB969Mu
- Organism SpeciesMus musculus (Mouse) Same name, Different species.
- Sample Typeserum, plasma and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Range0.312-20ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 0.132ng/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 575
For more details, please contact local distributors! US$ 821 US$ 3695 US$ 6979 US$ 57470
Specificity
This assay has high sensitivity and excellent specificity for detection of Mini Samples Complement Component 5 (C5).
No significant cross-reactivity or interference between Mini Samples Complement Component 5 (C5) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Mini Samples Complement Component 5 (C5) and the recovery rates were calculated by comparing the measured value to the expected amount of Mini Samples Complement Component 5 (C5) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 98-105 | 101 |
EDTA plasma(n=5) | 83-90 | 86 |
heparin plasma(n=5) | 89-102 | 94 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Mini Samples Complement Component 5 (C5) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Mini Samples Complement Component 5 (C5) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Mini Samples Complement Component 5 (C5) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 79-90% | 83-91% | 80-94% | 93-105% |
EDTA plasma(n=5) | 94-101% | 81-101% | 83-104% | 81-104% |
heparin plasma(n=5) | 94-101% | 94-101% | 79-94% | 81-90% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×60µL | Assay Diluent A | 1×6mL |
Detection Reagent B | 1×60µL | Assay Diluent B | 1×6mL |
TMB Substrate | 1×4.5mL | Stop Solution | 1×3mL |
Wash Buffer (30 × concentrate) | 1×10mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 25µL standard or sample to each well. Incubate 1 hour at 37°C;
3. Aspirate and add 25µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 25µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 25µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 20µL Stop Solution. Read at 450nm immediately.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
Journal of Clinical Immunology | Complement activation contributes to the injury and outcome of kidney in human anti-glomerular basement membrane disease. PubMed: 22941511 |
Journal of Neuroimmunology | Acute and prolonged complement activation in the central nervous system during herpes simplex encephalitis Pubmed:27235358 |
Cancer Letters | Complement C5a/C5aR pathway potentiates the pathogenesis Q5 of gastric cancer by down-regulating p21 expression pubmed:29031586 |
Proteomics Clinical Applications | iTRAQ‐Based Proteomic Analysis Reveals Protein Profile in Plasma from Children with Autism Pubmed:29274201 |
American journal of physiology. Endocrinology and metabolism | Impaired insulin signaling in the B10.D2-Hc H2 H2-T18/oSnJ mouse model of complement factor 5 (C5) deficiency Pubmed: 31084499 |
Proteomics Clinical Applications | Comparative proteomics analysis of serum proteins in gestational diabetes during early and middle stages of pregnancy Pubmed: 31162828 |
Aging | C5aR deficiency attenuates the breast cancer development via the p38/p21 axis Pubmed: 32669478 |
Catalog No. | Related products for research use of Mus musculus (Mouse) Organism species | Applications (RESEARCH USE ONLY!) |
RPB969Mu02 | Recombinant Complement Component 5 (C5) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB969Mu01 | Recombinant Complement Component 5 (C5) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB969Mu01 | Polyclonal Antibody to Complement Component 5 (C5) | WB; IHC; ICC; IP. |
PAB969Mu02 | Polyclonal Antibody to Complement Component 5 (C5) | WB; IHC; ICC; IP. |
WEB969Mu | Wide-range ELISA Kit for Complement Component 5 (C5) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SEB969Mu | ELISA Kit for Complement Component 5 (C5) | Enzyme-linked immunosorbent assay for Antigen Detection. |
MEB969Mu | Mini Samples ELISA Kit for Complement Component 5 (C5) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB969Mu | Multiplex Assay Kit for Complement Component 5 (C5) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |